274 related articles for article (PubMed ID: 18227486)
1. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
Lewis EJ; Xu X
Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
[TBL] [Abstract][Full Text] [Related]
2. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
[TBL] [Abstract][Full Text] [Related]
3. The role of heparanase in diseases of the glomeruli.
Szymczak M; Kuźniar J; Klinger M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
[TBL] [Abstract][Full Text] [Related]
4. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
5. Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy.
Tamsma JT; van der Woude FJ; Lemkes HH
Nephrol Dial Transplant; 1996 Jan; 11(1):182-5. PubMed ID: 8649631
[TBL] [Abstract][Full Text] [Related]
6. [ACE inhibitor effects on structure and function of the glomerular basement membrane].
Hasslacher C; Bostedt-Kiesel A; Kempe HP
Klin Wochenschr; 1992; 69 Suppl 29():39-44. PubMed ID: 1614191
[TBL] [Abstract][Full Text] [Related]
7. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
[TBL] [Abstract][Full Text] [Related]
8. Regulation of rat glomerular epithelial cell proteoglycans by high-glucose medium.
Kasinath BS; Block JA; Singh AK; Terhune WC; Maldonado R; Davalath S; Kallgren MJ; Wanna L
Arch Biochem Biophys; 1994 Feb; 309(1):149-59. PubMed ID: 8117103
[TBL] [Abstract][Full Text] [Related]
9. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium.
Kasinath BS; Grellier P; Choudhury GG; Abboud SL
J Cell Physiol; 1996 Apr; 167(1):131-6. PubMed ID: 8698830
[TBL] [Abstract][Full Text] [Related]
10. Increased albumin permeability in vitro following alterations of glomerular charge is mediated by the cells of the filtration barrier.
Daniels BS
J Lab Clin Med; 1994 Aug; 124(2):224-30. PubMed ID: 8051486
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy.
Makino H; Yamasaki Y; Haramoto T; Shikata K; Hironaka K; Ota Z; Kanwar YS
Lab Invest; 1993 Jan; 68(1):45-55. PubMed ID: 8423676
[TBL] [Abstract][Full Text] [Related]
12. Effect of galactose regimen on glomerular heparan sulfate synthesis and albumin excretion in diabetic rats.
Jaya B; Hu L; Bauman JW; Fu SC; Reddi AS
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):143-52. PubMed ID: 8321919
[TBL] [Abstract][Full Text] [Related]
13. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
[TBL] [Abstract][Full Text] [Related]
14. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.
Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N
Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105
[TBL] [Abstract][Full Text] [Related]
15. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
[TBL] [Abstract][Full Text] [Related]
16. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
Zalevskaia AG; Astamirova KhS; Karpova IA; Popova SG
Ter Arkh; 1998; 70(3):71-4. PubMed ID: 9575594
[TBL] [Abstract][Full Text] [Related]
17. Removal of heparan sulfate from the glomerular basement membrane blocks protein passage.
Wijnhoven TJ; Lensen JF; Wismans RG; Lefeber DJ; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
J Am Soc Nephrol; 2007 Dec; 18(12):3119-27. PubMed ID: 18003778
[TBL] [Abstract][Full Text] [Related]
18. Characterization of heparan sulfate isolated from drug glomerular basement membranes.
Linker A; Hovingh P; Kanwar YS; Farquhar MG
Lab Invest; 1981 Jun; 44(6):560-5. PubMed ID: 6453253
[TBL] [Abstract][Full Text] [Related]
19. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
[TBL] [Abstract][Full Text] [Related]
20. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients.
Maxhimer JB; Somenek M; Rao G; Pesce CE; Baldwin D; Gattuso P; Schwartz MM; Lewis EJ; Prinz RA; Xu X
Diabetes; 2005 Jul; 54(7):2172-8. PubMed ID: 15983219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]